Evaluation

Evaluation agreements allow a party to the deal to obtain rights to a technology or compound, subject to...

Evaluation agreements allow a party to the deal to obtain rights to a technology or compound, subject to a period of time to evaluate the quality, scope and applicability of the technology to its intended endpoint.

Evaluation agreements allow a party to the deal to obtain rights to a technology or compound, subject to a period of time to evaluate the quality, scope and applicability of the technology to its intended endpoint. Normally the technology is at an early stage and/or unproven and the partnering company wishes to assess the technology as part of the due diligence process in advance of signing a long term licensing agreement.

An Evaluation agreement is often tied in with an option agreement. Option and evaluation agreements are favoured by big pharma companies as they allow a company to access a number of new emerging technologies rather than just a few. Big Pharma companies tend to make most option and evaluation agreements annually.

To view an example of an evaluation agreement, please see the report below:

Option & Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

 

Glossary: Option

View also: Other technology type reports

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Print Friendly, PDF & Email